A leading ALS researcher whose recent study helps explain a problem that occurs with neurons controlling motor function has joined the University of Pittsburgh Brain Institute, where he’s focusing on the deadly disease process and compounds holding potential to treat or prevent it.

Christopher Donnelly recently left Johns Hopkins University to serve as assistant professor of neurobiology at the Pitt School of Medicine in the Live Like Lou Center for ALS Research, named for the patient advocacy organization started by Neil and Suzanne Alexander. Mr. Alexander died of ALS in March.

Amyotrophic lateral sclerosis commonly has been known as Lou Gehrig’s disease since the New York Yankee Hall-of-Fame first baseman died of it in 1941 at age 37.

“We are thrilled to have Dr. Donnelly bring his accomplishments and creativity to the Brain Institute,” Peter Strick, the institute’s scientific director, said in a release. “His research is taking our understanding of ALS therapeutics in new and promising directions.”

Advertise with us

Mr. Donnelly, who holds a Ph.D. in molecular biology, said he chose Pitt over other offers after Ms. Alexander and others offered their full support to his pursuit of an ALS treatment or cure. “There is humbled excellence here at the University of Pittsburgh and no bragging,” he said. “You do your work and do good science and try finding a cure for disease. There is no facade.”

Today the fourth annual LiveLikeLou Bike Ride is scheduled to raise funds for ALS, with the option of a 52-mile or 25-mile bike journey along the Great Allegheny Passage. Check-in begins at 7 a.m. at the Pump House on the Homestead Waterfront, 880 E. Waterfront Drive, with a post-race rally at noon. Information is available at www.livelikelou.org.

Mr. Donnelly co-led the recent study published in Nature focused on the previously identified DNA sequence leading to RNA that normally have three to five repeated sequences. But in the 10 percent of ALS patients who have a genetic or familial form of ALS, and possibly many more, the RNA can repeat itself 1,000 times. That large, sticky RNA mass produces errant proteins or on its own blocks channels through which healthful proteins travel to and from the nuclei of motor neurons, much like a traffic accident inside a tunnel. The blockage kills neuron cells, eventually making ALS patients unable to move and eventually breathe.

“One thing we see is that this process is not unique to ALS but also a common problem in aging and dementia,” said Mr. Donnelly, who’s studying the toxic RNA mechanism and ways to prevent or treat it.

David Templeton: dtempleton@post-gazette.com or 412-263-1578